Roots Analysis has announced the addition of “Companion Diagnostics Development Services Market (2nd Edition), 2022-2035” report to its list of offerings.

The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold.

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html

Key Market Insights

Over 150 companies claim to offer companion diagnostics development services, globally

Nearly 60% of the aforementioned players are based in North America, followed by the players located in Europe (30%). Further, this segment of the industry is dominated by the presence of mid-sized players (51-200 employees), which represent 40% of the total service providers.

Nearly 15% players claim to act as one-stop shops, offering services, ranging from biomarker discovery and development to manufacturing and commercialization

Most of the service providers (127) provide assay development services, followed by companies (124) offering services for biomarker discovery / identification. Further, NGS is the most popular technique, employed by over 100 service providers.

North America is expected to capture ~60% share in the companion diagnostics development services market by 2035

Owing to the high costs associated with the clinical validation of companion diagnostics, a significant proportion (~46%) of service revenues is generated from this step, in 2035. In terms of analytical technique used, service contracts involving NGS are anticipated to contribute to more than 35% of the total service revenues generated in 2035. Further, close to 90% of the total service revenues, in 2035, are generated from companion diagnostics development projects for cancer indications.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/297/request-sample.html

One of the key objectives of the report was to estimate the existing companion diagnostics market size and the potential future growth opportunities for companion diagnostics development service providers. Based on multiple parameters, such as the service cost of various steps involved in companion diagnostics development and manufacturing, and partnerships inked in the last few years for outsourcing of such operations, we have developed informed estimates on the evolution of the market for the time period 2022- 2035. An insightful analysis of companies segregated on the basis of their likelihood to enter into collaborations with companion diagnostics service providers. The chapter features a list of 300+ drug developers sponsoring clinical trials of therapies targeting several disease-specific biomarkers. The players have been shortlisted based on relevant parameters, namely number of biomarker-focused clinical trials sponsored and the time to market their proprietary personalized medicineproducts.

Key Questions Answered

§ Who are the leading players offering services for the development of companion diagnostics?

§ Which are the key geographies where companion diagnostics development service providers are located?

§ Which analytical techniques are used by the service providers engaged companion diagnostics development services market?

§ Who are the leading companion diagnostics developers?

§ Which biomarkers are most commonly targeted by the marketed products / investigational programs?

§ Which partnership models are commonly adopted by stakeholders offering companion diagnostics development services?

§ Which drug developers are most likely to partner with the service providers to seek their expertise?

§ What are the key value drivers of the merger and acquisition activity within companion diagnostics development services market?

§ Which biomarker-focused targeted drugs developed by big pharmaceutical companies are likely to be administered with companion diagnostics?

§ How is the current and future opportunity likely to be distributed across key market segments?

The financial opportunity within the companion diagnostics development services market has been analyzed across the following segments:

§ Type of Service Offered

§ Feasibility Studies

§ Assay Development

§ Analytical Validation

§ Clinical Validation

§ Manufacturing

§ Type of Technique Used

§ NGS

§ PCR

§ ICH / ISH

§ Liquid Biopsy

§ Others

§ Therapeutic Areas

§ Oncological

§ Non-oncological

§ Key Geographical Regions

§ North America

§ Europe

§ Asia-Pacific and Rest of the World

The research includes detailed profiles of key players (listed below), each profile features an overview of the company, its financial information (if available), drug portfolio, details on recent developments, and an informed future outlook.

§ Almac Diagnostic Services

§ BGI Genomics

§ Biocartis

§ Cerba Research

§ Geneuity Clinical Research Services

§ Interpace Biosciences

§ Labcorp (formerly known as Covance)

§ MEDICAL & BIOLOGICAL LABORATORIES (MBL)

§ MEDx (Suzhou) Translational Medicine (formerly known as QIAGEN (Suzhou) Translational Medicine)

§ MLM Medical Labs

§ Novogene

§ Q2 Solutions

§ Quest Diagnostics

§ ResearchDx

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html or email sales@rootsanalysis.com

You may also be interested in the following titles:

1. Targeted protein degradation market, 2022-2035

2. Cell Therapy Manufacturing Market, 2021-2030

3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

London

Roots Analysis has announced the addition of the “Cell Invasion and Migration Assays Market, 2022–2035” report to its list of offerings.

Owing to several advantages offered by cell invasion and migration assays in analyzing and quantifying cellular mechanisms, industry stakeholders have undertaken numerous R&D initiatives focused on exploiting the use of such assays to expediate discovery timelines and optimize the total development cost.

For additional details, please visit

https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market.html

Considering the various advantages offered by these cell-based assays, researchers across the globe have undertaken several initiatives to use these platforms for the diagnosis of a myriad of disease indications. The advancements in various technologies have propelled life science companies to use these assays in the drug discovery process, to enable the identification of potential lead candidates.

Key Market Insights

Presently, more than 80% of the total assay providers are based in North America

This segment of the industry is dominated by the presence of companies that were established pre-2000 (64%), followed by firms established during 2000-2010 (27%). In addition, most of the players engaged in this domain are small firms (less than 100 employees), representing over 45% of the total assay providers.

Currently, over 80 cell invasion and migration assays are available in the market

It is worth noting that most of the cell invasion and migration assays are currently being used for tumor studies (89%), followed by those employed for screening purposes (79%). Further, most of the assays are being developed for adherent cell cultures (48%), followed by those being manufactured for both adherent and suspension cell cultures (40%).

55% players claim to be capable of offering both cell invasion as well as cell migration assays

64% of the cell invasion and migration assays can be stored under frozen temperature (-18°C to -40°C), followed by those stored under refrigerated conditions (+1°C to +18°C) (36%). Further, it is worth noting that most of the cell invasion and migration assays are being used to conduct 100 tests (37%). This was followed by assays being developed to conduct 12 (35%) and 96 tests (23%).

Over 650 articles focused on cell invasion and migration assays have been published, since 2021

Majority of the scientific literature published in this domain was focused on research (96%), followed by review articles (4%). It is worth mentioning that articles related to cell invasion and migration assays have been affiliated by over 300 universities.

Patents filed / granted for cell invasion and migration assays have increased at a CAGR of more than 45%, since 2017

Of the total, around 55% of the patents were applications, followed by those that have been granted approval (45%). Around 63% of these intellectual property documents were filed / granted in North America; with the maximum number of patents having been filed in the US, since 2017.

More than 690 grants have been awarded to support the ongoing research efforts in this domain

Several non-profit organizations have extended financial support to aid the research related to cell invasion and migration assays. It is worth mentioning that NCI emerged as the most prominent non-profit organization, having awarded over 60% of grants, followed by NIGMS (17%).

North America and Asia-Pacific are anticipated to capture over 70% of the market share, in 2035

In terms of type of assay, the current market is driven by cell invasion assays (56%); this trend is unlikely to change in the foreseen future. Further, based on application area, assays intended for tumor studies are likely to have the maximum revenue generation potential (64%) in the overall market in 2035.

To request a sample copy / brochure of this report, please visit this

https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market/request-sample.html

Key Questions Answered

§ Which companies are engaged in offering cell invasion and migration assays kits?

§ What is the most common assay format (in terms of number of wells) offered by cell invasion and migration assay providers?

§ What are the key geographical regions where cell invasion and migration assay providers are located?

§ What is the evolving trend of publications focused on cell invasion and migration assays?

§ Which companies are actively filing patents to drive innovation in the field of cell invasion and migration assays?

§ What are the key factors influencing the price of cell invasion and migration assays?

§ What are the key challenges associated with cell invasion and migration assays?

§ How is the current and future market opportunity likely to be distributed across key market segments?

The financial opportunity within the cell invasion and migration assays market has been analyzed across the following segments:

§ Type of Assay

§ Cell Invasion Assay

§ Cell Migration Assay

§ Application Area

§ Drug Discovery

§ Screening

§ Tumor Study

§ Detection Method Used

§ Colorimetry

§ Fluorometry

§ Key Geographical Regions

§ North America

§ Europe

§ Asia-Pacific

§ Latin America

§ MENA

§ Rest of the World

The report includes profiles of key players (listed below); each profile features an overview of the company, details related to its product portfolio dedicated to cell invasion and migration assays, recent developments and an informed future outlook.

§ Abcam

§ BioVision

§ Enzo Life Science

§ MilliporeSigma

§ R&D Systems

§ Sigma-Aldrich

For additional details, please visit

https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market.html

You may also be interested in the following titles:

1. Targeted protein degradation market, 2022-2035

2. Cell Therapy Manufacturing Market, 2021-2030

3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

During our research, we were able to identify more than 60 developers were involved in the development of RNA extraction and purification kits and reagents. The RNA extraction and purification kits market is currently dominated by the presence of small companies. This is followed by the presence of well-established players in this domain.

For additional details, please visit

https://www.rootsanalysis.com/reports/rna-extraction-and-purification.html

Further, most of the manufacturers of RNA extraction kits are headquartered in North America. Within this region, the US has emerged as the most prominent region, having the highest number of manufacturers. This is followed by the number of stakeholders headquartered in Asia-Pacific, with China and India being the base of operations for seven companies engaged in this domain. As can be observed in the figure, majority of the kits employ spin column technology for RNA extraction and purification. This is followed by the number of kits that employ magnetic beads technologies for the extraction and RNA purification. Further, maximum number of the kits have the ability to extract total RNA, followed by the kits that can extract viral RNA.

To request a sample copy / brochure of this report, please visit this

https://www.rootsanalysis.com/reports/rna-extraction-and-purification/request-sample.html

It is evident from the figure that over 80% of the RNA isolated using RNA extraction and purification kits are used for PCR / RT-PCR applications, whereas 49% isolated RNA are used for blotting applications. It is worth mentioning that close to 50% kits are used to isolate RNA for SARS-CoV-2 analysis. With the increasing adoption of molecular diagnostics and introduction of novel and advanced RNA extraction and purification techniques, the RNA isolation and purification market is anticipated to witness steady growth in the coming years.

For additional details, please visit

https://www.rootsanalysis.com/reports/rna-extraction-and-purification.html

You may also be interested in the following titles:

1. Targeted protein degradation market, 2022-2035

2. Cell Therapy Manufacturing Market, 2021-2030

3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Roots Analysis has announced the addition of “Automatic Samplingin Biopharmaceutical Applications and the Measurement of CQA, 2022-2035” report to its list of offerings.

The automatic sampling systems have diverse applications, including bioprocess / analyte monitoring, data management and advanced process control / feedback control, in biotechnology and pharmaceutical industries.

To order this 230+ page report, which features 120+ figures and 140+ tables, please visit

https://www.rootsanalysis.com/reports/automatic-sampling-market.html

Key Market Insights

Currently, more than 55 automatic sampling systems are available in the market

Majority (71%) of the automatic sampling systems are capable of on-line monitoring, followed by off-line (22%) and at-line monitoring (7%). It is worth noting that around 25% of the automatic sampling systems offer multiplexer module for withdrawing the sterile samples, followed by systems containing routing module (23%) that can transfer the sample to various analyzers.

Around 45 companies are presently engaged in the manufacturing of automatic sampling systems, globally

The automatic sampling industry is dominated by the presence of mid-sized players (51-200 employees), representing more than 40% of the total automatic sampling system manufacturers. Further, about 15% firms were established post-2010. In addition, majority (54%) of the players engaged in this domain are based in Europe, followed by North America (32%).

Close to 20 automatic sample collection / preparation systems are presently available

Majority of the automatic sample collection / preparation systems (84%) are stand-alone systems. This is followed by integrated systems which capture 16% share in this domain. Further, most of these systems (nearly 40%) are being used in the pharmaceutical industry, followed by the biotechnology industry (35%).

Over 400 patents related to automatic sampling in biopharmaceutical industryhave been filed / granted, since 2016

Owing to the increase in research and development efforts led by several industry and non-industry players engaged in this domain, close to 50% of patent applications have been filed post-2016. It is worth noting that 56% patents related to automatic sampling systems were filed / granted in the US alone.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/automatic-sampling-market.html

Key Questions Answered

§ Who are the key players engaged in the development of automatic sampling systems?

§ What is the relative competitiveness of different automatic sampling system manufacturers?

§ Who are the leading manufacturers involved in the automatic sample collection / preparation systems market?

§ How has the intellectual property landscape of automatic sampling systems evolved over the years?

§ What are the key agenda items being discussed in the various global events / conferences related to automatic sampling systems?

§ Which partnership models are most commonly adopted by stakeholders engaged in the automatic sampling industry?

§ How is the current and future market opportunity, likely to be distributed across key market segments?

The financial opportunity within the automatic sampling market has been analyzed across the following segments:

§ Type of Monitoring Method

§ On-line

§ Off-line

§ At-line

§ Bioprocessing Method

§ Upstream

§ Downstream

§ Working Volume

§ Less than 10 mL

§ 10-50 mL

§ 51-100 mL

§ More than 100 mL

§ Scalability

§ Lab

§ Pilot

§ Commercial

§ Key Geographical Regions

§ North America

§ Europe

§ Asia-Pacific and Rest of the World

The research also includes detailed profiles of the key players (listed below) engaged in the manufacturing of automatic sampling systems; each profile features an overview of the company, its financial information (if available), details on product portfolio, recent developments and an informed future outlook.

§ Agilent Technologies

§ Cytiva

§ Mettler Toledo

§ Pall Corporation

§ Shimadzu

§ Xylem

For additional details, please visit

https://www.rootsanalysis.com/reports/automatic-sampling-market.html

or email sales@rootsanalysis.com

You may also be interested in the following titles:

1. Medical Device CRO MARKET , 2022-2035

2. Needlestick Safety Injection Devices Market, 2022-2035

3. Single-Use Downstream Bioprocessing Technology Market, 2022-2035

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list of offerings.

With 13 drugs approved in the European Union and the US, Fc fusion therapeutics are considered to be one of the most successful classes of IgG-based products. The success of these biopharmaceutical products can be attributed to their diverse biological and pharmacological properties, including an extended serum half-life

To order this 130+ page report, which features 95+ figures and 140+ tables, please visit https://www.rootsanalysis.com/reports/fc-fusion-therapeutics-market.html

Key Market Insights

Presently, more than 115 Fc fusion therapeutics are approved / under development

Over 60% of the aforementioned candidates are being evaluated in clinical stages; of these, 50 molecules are in advanced phases (Phase II and above) of clinical trials. This is followed by more than 30% of the Fc fusion therapeutics which are already marketed for various disease indications. It is worth noting that majority of the pipeline therapies (18) are being developed to target PD-L1 for the treatment of oncological disorders.

More than 25 companies claim to be engaged in the development of Fc fusion therapeutics

Post 2001, there has been a significant rise in the number of companies working in this domain. It is worth noting that majority (48%) of the firms engaged in this domain are based in North America, followed by those headquartered in Asia-Pacific (38%) and Europe (3%).

Over 1,450 clinical trials have been registered for the evaluation of Fc fusion therapeutics, globally

Of these, most of the trials were / are being conducted in North America (48%). Within this region, more than 50% of the total patients were enrolled in trials focused on the evaluation of these therapeutics. This was followed by studies being conducted in Europe and Asia Pacific.

Close to 200 grants have been awarded to support research on Fc fusion therapeutics, since 2010

Around USD 68 million have been awarded to various organizations working in this domain, since 2010. Further, almost 80% of the total grants were awarded for a support period of 1-5 years.

At present, therapies targeting ophthalmological disorders represent majority of the market share (in terms of sales revenue)

We believe that, in the foreseen future the trend is likely to remain the same. The market opportunity within this therapeutic area is likely to be distributed among indications, such as ophthalmological disorders, and hematological diseases. This is followed by genetic disorders which represent over 30% of the market share.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/fc-fusion-therapeutics-market.html

Key Questions Answered

§ Who are the leading players involved in the development of Fc fusion therapeutics?

§ Which geographies are the most active in conducting clinical trials on Fc fusion therapeutics?

§ Which are the leading funding organizations providing grants for Fc fusion therapeutics?

§ Which partnership models are commonly adopted by industry stakeholders engaged in the Fc fusion therapeutics market?

§ How is the current and future market opportunity likely to be distributed across key market segments?

For additional details, please visit

https://www.rootsanalysis.com/reports/fc-fusion-therapeutics-market.html

or email sales@rootsanalysis.com

You may also be interested in the following titles:

1. Regulatory T-Cell Therapies (Tregs) Market, 2021–2035

2. CD47 Targeting Therapeutics Market, 2021-2035

3. Light Activated Therapies Market, 2021-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Roots Analysis has announced the addition of DNA Data Storage Market, 2021-2035” report to its list of offerings.

DNA as a data storage medium helps eliminate the drawbacks inherent to the traditional storage methods, such as limited storage density, instability and limited life span, making it a potential storage option for future.

To order this 240+ page report, which features 75+ figures and 90+ tables, please visit https://www.rootsanalysis.com/reports/dna-data-storage-market.html

Key Market Insights

Presently, more than 20 players claim to offer DNA Data Storage

Over 40% of these players are involved in offering technologies / services for coding and DNA writing (DNA synthesis), followed by those offering services for retrieval and DNA reading (29%). It is worth mentioning that 10 technology / service providers claim to have the required expertise to serve as one-stop-shops for all the DNA data storage steps.

Over 350 grants have been awarded to support research on DNA data storage, since 2016

Grants worth USD 517 million have been awarded to various organizations working in this domain during the period, 2016- 2021. Of these, 33% of the grants were awarded to support the research related to projects on DNA data storage, were / are being managed by NCI, followed by those managed by NIA (11%), NINDS (9%) and NIDDK (6%).

Over 900 patents have been filed / granted related to DNA data storage, since 2001

More than 50% of these patents were filed / granted in North America, followed by Europe (39%). In addition to the industry players, patents related to DNA data storage were also filed by academic institutes, such as Massachusetts Institute of Technology, Harvard University and University of Arkansas.

Partnership activity within this domain has grown significantly at a CAGR of 32%

More than 55% of the agreements were established in 2020. Majority of these deals were product development and commercialization agreements (21%), acquisitions (17%), technology licensing deals (17%), and manufacturing agreements (13%).

Funding and investment in this domain have increased significantly, highlighting the growing demand for DNA data storage systems

Around USD 1 billion was raised by companies, across various funding rounds in 2020. Majority of the companies raised significant capital through venture capital financing (~USD 417 million). It is worth highlighting that over 50% of the funding instances were reported by companies headquartered in North America, followed by Europe.

North America is expected to capture over 55% of the DNA data storage market share by 2035 Within North America, US is likely to capture the maximum share. Further, in terms of step involved in DNA based data storage, the coding and DNA writing step is likely to capture the highest market share (86%).

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/dna-data-storage-market.html

Key Questions Answered

§ Who are the leading industry players involved in offering services or technologies related to DNA data storage?

§ Which are the leading funding organizations providing grants for research on DNA data storage?

§ How has the intellectual property landscape of DNA data storage evolved over the years?

§ Which partnership models are commonly adopted by industry stakeholders offering services or technologies related to DNA data storage?

§ What is the trend of capital investments in the DNA data storage market?

§ How is the current and future market opportunity likely to be distributed across key market segments?

The financial opportunity within the DNA data storage market has been analyzed across the following segments:

§ DNA Data Storage Steps

§ Coding and DNA Writing (DNA Synthesis)

§ DNA Storage

§ Retrieval and DNA Reading (DNA Sequencing)

§ Geographical Regions

§ North America

§ Europe

The research includes detailed profiles of key players (listed below); each profile features an overview of the company, its financial information (if available), details on the technology / services offered, recent developments, and an informed future outlook.

§ Agilent Technologies

§ ATUM

§ Codex DNA

§ Gattaca Technologies

§ GenScript

§ Illumina

§ Imagene

§ Oxford Nanopore Technologies

§ Synbio Technologies

For additional details, please visit

https://www.rootsanalysis.com/reports/dna-data-storage-market.html

or email sales@rootsanalysis.com

You may also be interested in the following titles:

1. Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market, 2021-2030

2. Digital Solutions for Biomarkers Market, 2021-2030

3. AI-based Drug Discovery Market, 2020-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Roots Analysis has announced the addition of “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” report to its list of offerings.

To order this 500+ page report, which features 160+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html

Key Market Insights

Nearly 230 digital therapeutic solutions are currently available / under development

Close to 45% of the aforementioned solutions are standalone software applications targeting more than 60 unique indications.

Over 85% of digital therapeutic solutions are intended to replace medication

Such solutions are currently available / being developed to treat neurological disorders (27%), mental health problems (24%), and certain metabolic disorders (24%). Alternatively, some digital health products are designed to augment the effect of conventional therapeutics and are currently being considered for treating substance use disorders and few mental health problems.

220+ clinical trials, focused on digital therapeutics, have been registered since 2004

Around 80,000 patients have been enrolled in clinical research initiatives aimed to validate the efficacy of digital therapeutics, and generate real world evidence concerning their efficacy and safety. Close to 50% of such trials have been / are being conducted in the US.

To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/208/request-sample.html

One of the key objectives of the report was to estimate the existing digital health market size and the future opportunity for digital therapeutics developers over the next decade.

A discussion on affiliated digital health market trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution.

Key Questions Answered

§ Who are the leading players engaged in the development of digital therapeutic solutions?

§ What are the most popular therapeutic areas addressed by digital health solutions?

§ What are the key factors influencing the price of digital therapeutics?

§ What is the trend of capital investments in the digital therapeutics market?

§ Which partnership models are commonly adopted by stakeholders in this industry?

§ What type of marketing strategies are being adopted by developers in this domain?

§ How is the COVID-19 pandemic likely to impact the digital therapeutics market?

§ How is the current and future opportunity likely to be distributed across key market segments?

§ What are the anticipated future trends related to digital therapeutics?

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/208.html

You may also be interested in the following titles:

1. AR / VR Based Healthcare Digital Marketing Service ProvidersMarket, 2020-2030

2. AI-Based Clinical Trial Solution ProvidersMarket, 2020-2030

3. Global Handheld Ultrasound Imaging DevicesMarket, 2020-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.

The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced technologies to cater to the evolving needs. It is also worth highlighting that stakeholders engaged in this domain are actively undertaking initiatives to develop interventions for SARS-CoV-2 virus.

To order this 450+ page report, which features 120+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html

Key Market Insights

Presently, more than 80 players claim to offer services for antibody discovery

Over 90% of the aforementioned players provide services for hit generation, followed by those offering services for antibody humanization (58%). It is worth mentioning that five service providers claim to have the required expertise to serve as one-stop-shops for all the antibody discovery steps.

More than 120 companies offer antibody discovery platforms

It is worth highlighting that close to 180 technologies focused on antibody discovery are presently available in the market. Further, nearly 50% platforms use library-based methods to discover antibodies. Amongst these, phage display is currently the most widely used technique. This is followed by single cell-based methods (20%).

The licensing market opportunity for antibody discovery platforms is anticipated to grow at a CAGR of close to 10%, during 2020-2030

By 2030, North America is estimated to capture over 50% (in terms of revenues generated) share of the antibody discovery platforms market. It is worth mentioning that the market for antibody discovery platforms in Asia-pacific is anticipated to grow at a relatively faster pace, during the forecast period.

To request a sample copy / brochure of this report, please visit this -https://www.rootsanalysis.com/reports/213/request-sample.html

Key Questions Answered

§ Who are the leading players engaged in offering services and platforms for antibody discovery?

§ What are the most popular types of services offered for antibody discovery?

§ Who are the key opinion leaders from renowned academic and research institutes that can help you drive efforts related to antibody discovery?

§ What is the trend of capital investments being made in the antibody discovery market?

§ Which partnership models are most commonly adopted by stakeholders engaged in this industry?

§ What are the opportunities for antibody discovery service and platform providers in emerging markets?

§ How is the current and future opportunity likely to be distributed across key market segments?

The USD 6.5 billion (by 2030) financial opportunity within the antibody discovery services market has been analyzed across the following segments:

§ Steps Involved in the Antibody Discovery Process

Antigen Designing

Hit Generation

Lead Selection

Lead Optimization

Lead Characterization

§ Antibody Discovery Method Used

Phage Display

Hybridoma

Transgenic Animal

Yeast Display

Single Cell

Others

§ Nature of Antibody Generated

Humanized

Human

Chimeric

Murine

§ Key Geographical Regions

North America

Europe

Asia Pacific and Rest of the World

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html

or email sales@rootsanalysis.com

You may also be interested in the following titles:

Antibody Contract Manufacturing Market, 2020 – 2030

Antibody Drug Conjugates Market (5th Edition), 2019-2030

Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.”

The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe.

For more information please click on the following link

https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html

Amongst other elements, the report includes:

§ A detailed review of the current Medical Device CRO market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain.

§ A detailed discussion on the need for regulatory review / oversight across different stages of the medical devices supply chain, with emphasis on the optimization of the supply chain using upcoming tools / technologies.

§ An elaborate discussion on the various guidelines established by major regulatory bodies for medical device approval across North America, Europe, Asia-Pacific and rest of the world.

§ An elaborate discussion on the various outsourcing business models adopted for regulatory affairs management, along with an insightful Harvey ball analysis of key considerations that need to be assessed by industry stakeholders while selecting a CRO partner.

§ An analysis highlighting the key performance indicators used by sponsor companies to evaluate service providers that are active in the domain, based on information gathered via secondary research (for top-ten medical device players) and primary research.

§ A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing regulatory affairs management services to medical device developers.

For more information please click on the following link

https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html

Other Recent Offerings

1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030

2. Medical Device Labels Manufacturing Market, 2019-2030

3. Medical Device Contract Manufacturing Market, 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Roots Analysis has announced the addition of “Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030” report to its list of offerings.

The report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing industry.

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/pharmaceutical-contract-manufacturing-market/191.html

§ A detailed overview of the overall market landscape, featuring an elaborate list of over 450 active CMOs engaged in this domain, along with information on several relevant parameters, such as year of establishment, company size, geographical location of CMOs, type of business segment (active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs)), type of API(s) manufactured (complex, generic and sterile), type of FDF(s) offered (oral solids, liquids / semi-solids, injectables, inhalation and others), type of service(s) offered, type of primary packaging form (blister, tubes, vial / cartridge, ampoule, sachets / pouches / bags, inhalers / nasal sprays, glass / plastic / dropper bottles, pre-filled syringes / autoinjectors), scale of operation (preclinical, clinical and commercial) and specific location of manufacturing facilities (country-wise).

§ A detailed analysis of various mergers and acquisitions that have taken place in this domain, highlighting the trend in number of companies acquired and geographical distribution of the activity, during the period 2017-2021. Further, it highlights the relationship between deal multiples (based on revenues), number of employees and experience of the acquired firm.

§ A detailed discussion on various guidelines laid down by major regulatory bodies, across different countries, featuring an elaborative assessment of over 450 CMOs engaged in this domain, along with information on their operational approvals, certifications received, and relative popularity of the key regulatory body. Additionally, the chapter features an insightful multi-dimensional bubble analysis, presenting a comparison of the current regulatory scenario in key geographies.

§ Elaborate profiles of key players engaged in offering pharmaceutical contract manufacturing services. Each profile features a brief overview of the company, along with information on its financial performance (if available), service(s) portfolio, manufacturing facilities and capabilities, recent developments and an informed future outlook.

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/191/request-sample.html

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/pharmaceutical-contract-manufacturing-market/191.html or email sales@rootsanalysis.com

Other Recent Offerings

1. Vaccine Contract Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, 2021-2030

2. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030

3. Biopharmaceutical Contract Manufacturing Market (4th Edition): Industry Trends and Global Forecasts, 2021-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/